Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk
2010

Testosterone Levels and Breast Cancer Risk in Premenopausal Women

Sample size: 266 publication 10 minutes Evidence: moderate

Author Information

Author(s): Joanne F Dorgan, Frank Z Stanczyk, Lisa L Kahle, Louise A Brinton

Primary Institution: Fox Chase Cancer Center

Hypothesis

Are premenopausal serum estradiol and testosterone levels associated with breast cancer risk?

Conclusion

Premenopausal women with elevated serum testosterone levels are at an increased risk of breast cancer.

Supporting Evidence

  • Serum testosterone was significantly associated with breast cancer risk.
  • Total and non-SHBG-bound estradiol were not associated with breast cancer.
  • Cases had higher geometric mean testosterone concentrations than controls.

Takeaway

This study found that women who had higher testosterone levels before menopause were more likely to develop breast cancer later on.

Methodology

A prospective case-control study with 98 breast cancer cases and 168 matched controls, analyzing hormone levels using specific assays.

Potential Biases

Potential bias due to self-reported data and matching criteria relaxation.

Limitations

The study had a relatively small sample size and limited power for stratified analyses.

Participant Demographics

All participants were premenopausal women, primarily white, with an average age of 44.7 years.

Statistical Information

P-Value

0.006

Confidence Interval

95% CI, 1.6 to 10.9

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr2779

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication